Vor Biopharma (VOR) Stock Price
Vor Biopharma Price
The consensus 12-month price target for Vor Biopharma is 29.00 USD, about 46.3% above where the stock trades today. Of 13 analysts, 11 rate the stock a buy — an overall Buy consensus.
Vor Biopharma stock price
Vor Biopharma business model & stock analysis
Frequently asked questions about Vor Biopharma
Analysts currently set an average price target of 29.00 USD for the Vor Biopharma stock (median: 29.00 USD), implying +46.3 % versus the latest price. The consensus is based on 13 analyst ratings.
13 analysts currently rate the Vor Biopharma stock: 11 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Vor Biopharma to generate revenue of 4.17 M USD and earnings per share of -30.34 USD.
Converted at the current exchange rate, the Vor Biopharma share trades at 17.69 EUR (19.82 USD).
The Vor Biopharma share (VOR) is listed on 1 stock exchanges, including: NASDAQ (VOR).
The expected revenue of Vor Biopharma is 4.17 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Vor Biopharma is -299.53 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Vor Biopharma is currently -0.65. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Vor Biopharma stock.
The price-to-sales ratio (P/S) of Vor Biopharma is currently 46.96. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Vor Biopharma stock.
The Eulerpool Quality Score for Vor Biopharma is 2/10.
The ISIN of Vor Biopharma is US9290332074. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Vor Biopharma is VOR. The ticker symbol is used to trade Vor Biopharma shares on the stock exchange.
Vor Biopharma stock
Vor Biopharma Peer Group
Vor Biopharma Ticker
All fundamentals and in-depth analysis of Vor Biopharma
Our stock analysis for Vor Biopharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vor Biopharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.